Study title:
Marshall BC, Koch WC. Antivirals for cytomegalovirus
infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events.Paediatr Drugs.
2009;11(5):309-21.Marshall BC, Koch WC. Antivirals for cytomegalovirus
infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events.Paediatr Drugs.
2009;11(5):309-21.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Virus Diseases [C02]
|
Brands: Please see report, Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: Foscarnet |
ATC code: |
Document link:
Marshall BC et al 2009.pdf
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Review Article |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|